Prozac, developed by Eli Lilly, is a leading brand in the treatment of depression, anxiety disorders, and certain other mental health conditions. As a selective serotonin reuptake inhibitor (SSRI), Prozac works by increasing levels of serotonin in the brain, which helps improve mood and alleviate symptoms of depression and anxiety. Known for its effectiveness and favorable safety profile, Prozac has become a trusted name in psychiatric care. Eli Lilly’s commitment to innovation and patient support is reflected in the extensive clinical research backing Prozac, as well as its emphasis on accessibility and education for patients and healthcare providers. By offering a reliable and well-tolerated treatment option, Prozac continues to play a vital role in improving mental health and enhancing the quality of life for individuals managing mood disorders.